ID   ITA7_RAT                Reviewed;        1135 AA.
AC   Q63258; Q5HZX9; Q63026; Q63027;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   10-JUL-2007, sequence version 2.
DT   29-MAY-2024, entry version 162.
DE   RecName: Full=Integrin alpha-7;
DE   AltName: Full=H36-alpha7;
DE   Contains:
DE     RecName: Full=Integrin alpha-7 heavy chain;
DE   Contains:
DE     RecName: Full=Integrin alpha-7 light chain;
DE   Contains:
DE     RecName: Full=Integrin alpha-7 70 kDa form;
DE   Flags: Precursor;
GN   Name=Itga7;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM ALPHA-7X1B).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 34-1135 (ISOFORM ALPHA-7X1B).
RC   TISSUE=Skeletal muscle;
RX   PubMed=1315319; DOI=10.1083/jcb.117.3.643;
RA   Song W.K., Wang W., Foster R.F., Bielser D.A., Kaufman S.J.;
RT   "H36-alpha 7 is a novel integrin alpha chain that is developmentally
RT   regulated during skeletal myogenesis.";
RL   J. Cell Biol. 117:643-657(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 969-1135 (ISOFORMS ALPHA-7X1A AND
RP   ALPHA-7X1C).
RC   TISSUE=Skeletal muscle;
RX   PubMed=8126096; DOI=10.1242/jcs.106.4.1139;
RA   Song W.K., Wang W., Sato H., Bielser D.A., Kaufman S.J.;
RT   "Expression of alpha 7 integrin cytoplasmic domains during skeletal muscle
RT   development: alternate forms, conformational change, and homologies with
RT   serine/threonine kinases and tyrosine phosphatases.";
RL   J. Cell Sci. 106:1139-1152(1993).
RN   [4]
RP   TISSUE SPECIFICITY.
RX   PubMed=8626012; DOI=10.1006/dbio.1996.0057;
RA   Martin P.T., Kaufman S.J., Kramer R.H., Sanes J.R.;
RT   "Synaptic integrins in developing, adult, and mutant muscle: selective
RT   association of alpha1, alpha7A, and alpha7B integrins with the
RT   neuromuscular junction.";
RL   Dev. Biol. 174:125-139(1996).
RN   [5]
RP   FUNCTION.
RX   PubMed=17598176; DOI=10.1002/glia.20536;
RA   Chernousov M.A., Kaufman S.J., Stahl R.C., Rothblum K., Carey D.J.;
RT   "Alpha7beta1 integrin is a receptor for laminin-2 on Schwann cells.";
RL   Glia 55:1134-1144(2007).
RN   [6]
RP   CLEAVAGE BY UROKINASE, AND MUTAGENESIS OF ARG-603.
RX   PubMed=18940796; DOI=10.1074/jbc.m804661200;
RA   Liu J., Gurpur P.B., Kaufman S.J.;
RT   "Genetically determined proteolytic cleavage modulates alpha7beta1 integrin
RT   function.";
RL   J. Biol. Chem. 283:35668-35678(2008).
RN   [7]
RP   FUNCTION, AND INTERACTION WITH COMP.
RX   PubMed=20019333; DOI=10.1161/circresaha.109.202762;
RA   Wang L., Zheng J., Du Y., Huang Y., Li J., Liu B., Liu C.J., Zhu Y.,
RA   Gao Y., Xu Q., Kong W., Wang X.;
RT   "Cartilage oligomeric matrix protein maintains the contractile phenotype of
RT   vascular smooth muscle cells by interacting with alpha(7)beta(1)
RT   integrin.";
RL   Circ. Res. 106:514-525(2010).
CC   -!- FUNCTION: Integrin alpha-7/beta-1 is the primary laminin receptor on
CC       skeletal myoblasts and adult myofibers. During myogenic
CC       differentiation, it may induce changes in the shape and mobility of
CC       myoblasts, and facilitate their localization at laminin-rich sites of
CC       secondary fiber formation. Involved in the maintenance of the myofibers
CC       cytoarchitecture as well as for their anchorage, viability and
CC       functional integrity. Required to promote contractile phenotype
CC       acquisition in differentiated airway smooth muscle (ASM) cells (By
CC       similarity). Acts as a Schwann cell receptor for laminin-2. Acts as a
CC       receptor of COMP and mediates its effect on vascular smooth muscle
CC       cells (VSMCs) maturation. {ECO:0000250, ECO:0000269|PubMed:17598176,
CC       ECO:0000269|PubMed:20019333}.
CC   -!- SUBUNIT: Interacts (via C-terminus intracellular tail region) with
CC       CIB1; the interaction is stabilized/increased in a calcium- and
CC       magnesium-dependent manner (By similarity). Heterodimer of an alpha and
CC       a beta subunit. The alpha subunit is composed of a heavy and a light
CC       chain linked by a disulfide bond. Alpha-7 associates with beta-1.
CC       Interacts with COMP. {ECO:0000250, ECO:0000269|PubMed:20019333}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=Alpha-7X1B;
CC         IsoId=Q63258-1; Sequence=Displayed;
CC       Name=Alpha-7X1A;
CC         IsoId=Q63258-2; Sequence=VSP_002734;
CC       Name=Alpha-7X1C;
CC         IsoId=Q63258-3; Sequence=VSP_002735;
CC   -!- TISSUE SPECIFICITY: Expressed in skeletal and cardiac muscle. Expressed
CC       in replicating myoblasts. In differentiated muscle fibers localizes
CC       between fibers and the surrounding matrix. Isoform Alpha-7X1A and
CC       isoform Alpha-7X1B are expressed at myotendinous and neuromuscular
CC       junctions; isoform Alpha-7X1C is expressed at neuromuscular junctions
CC       and at extrasynaptic sites. {ECO:0000269|PubMed:8626012}.
CC   -!- DEVELOPMENTAL STAGE: Isoforms are developmentally regulated during the
CC       formation of skeletal muscle. Isoform Alpha-7X1A and isoform Alpha-7X1C
CC       are induced upon terminal myogenic differentiation; isoform Alpha-7X1B
CC       is present earlier in replicating cells and diminishes upon
CC       differentiation.
CC   -!- PTM: ADP-ribosylated on at least two sites of the extracellular domain
CC       in skeletal myotubes. {ECO:0000250}.
CC   -!- PTM: A 70 kDa form is created by proteolytic cleavage. Cleavage is
CC       elevated during myogenic differentiation and the cleaved form enhances
CC       cell adhesion and spreading on laminin. {ECO:0000269|PubMed:18940796}.
CC   -!- SIMILARITY: Belongs to the integrin alpha chain family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC088846; AAH88846.1; -; mRNA.
DR   EMBL; X65036; CAA46170.1; -; mRNA.
DR   EMBL; X74293; CAA52346.1; -; mRNA.
DR   EMBL; X74294; CAA52347.1; -; mRNA.
DR   PIR; S38783; S38783.
DR   PIR; S40148; S40148.
DR   PIR; S40149; S40149.
DR   RefSeq; NP_110469.1; NM_030842.1. [Q63258-1]
DR   AlphaFoldDB; Q63258; -.
DR   SMR; Q63258; -.
DR   BioGRID; 249497; 2.
DR   CORUM; Q63258; -.
DR   IntAct; Q63258; 1.
DR   STRING; 10116.ENSRNOP00000028983; -.
DR   GlyCosmos; Q63258; 5 sites, No reported glycans.
DR   GlyGen; Q63258; 5 sites.
DR   iPTMnet; Q63258; -.
DR   PhosphoSitePlus; Q63258; -.
DR   SwissPalm; Q63258; -.
DR   PaxDb; 10116-ENSRNOP00000058370; -.
DR   GeneID; 81008; -.
DR   KEGG; rno:81008; -.
DR   UCSC; RGD:71022; rat. [Q63258-1]
DR   AGR; RGD:71022; -.
DR   CTD; 3679; -.
DR   RGD; 71022; Itga7.
DR   VEuPathDB; HostDB:ENSRNOG00000007905; -.
DR   eggNOG; KOG3637; Eukaryota.
DR   HOGENOM; CLU_004111_1_0_1; -.
DR   InParanoid; Q63258; -.
DR   OrthoDB; 3816176at2759; -.
DR   PhylomeDB; Q63258; -.
DR   Reactome; R-RNO-3000157; Laminin interactions.
DR   Reactome; R-RNO-3000178; ECM proteoglycans.
DR   PRO; PR:Q63258; -.
DR   Proteomes; UP000002494; Chromosome 7.
DR   Bgee; ENSRNOG00000007905; Expressed in heart and 19 other cell types or tissues.
DR   ExpressionAtlas; Q63258; baseline and differential.
DR   GO; GO:0009986; C:cell surface; IDA:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0009897; C:external side of plasma membrane; IBA:GO_Central.
DR   GO; GO:0034677; C:integrin alpha7-beta1 complex; ISO:RGD.
DR   GO; GO:0008305; C:integrin complex; IDA:RGD.
DR   GO; GO:0005927; C:muscle tendon junction; ISO:RGD.
DR   GO; GO:0031594; C:neuromuscular junction; ISO:RGD.
DR   GO; GO:0042383; C:sarcolemma; ISO:RGD.
DR   GO; GO:0050839; F:cell adhesion molecule binding; IDA:RGD.
DR   GO; GO:0005178; F:integrin binding; IPI:RGD.
DR   GO; GO:0043236; F:laminin binding; IDA:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:RGD.
DR   GO; GO:0048514; P:blood vessel morphogenesis; ISO:RGD.
DR   GO; GO:0007155; P:cell adhesion; IDA:RGD.
DR   GO; GO:0033627; P:cell adhesion mediated by integrin; IBA:GO_Central.
DR   GO; GO:0016477; P:cell migration; ISO:RGD.
DR   GO; GO:0098609; P:cell-cell adhesion; IBA:GO_Central.
DR   GO; GO:0007160; P:cell-matrix adhesion; IBA:GO_Central.
DR   GO; GO:0035987; P:endodermal cell differentiation; ISO:RGD.
DR   GO; GO:0034113; P:heterotypic cell-cell adhesion; ISO:RGD.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IDA:RGD.
DR   GO; GO:0050900; P:leukocyte migration; IBA:GO_Central.
DR   GO; GO:0008360; P:regulation of cell shape; IEA:UniProtKB-KW.
DR   GO; GO:0007519; P:skeletal muscle tissue development; IEP:RGD.
DR   Gene3D; 1.20.5.930; Bicelle-embedded integrin alpha(iib) transmembrane segment; 1.
DR   Gene3D; 2.130.10.130; Integrin alpha, N-terminal; 1.
DR   Gene3D; 2.60.40.1460; Integrin domains. Chain A, domain 2; 1.
DR   Gene3D; 2.60.40.1510; ntegrin, alpha v. Chain A, domain 3; 1.
DR   Gene3D; 2.60.40.1530; ntegrin, alpha v. Chain A, domain 4; 1.
DR   InterPro; IPR013517; FG-GAP.
DR   InterPro; IPR013519; Int_alpha_beta-p.
DR   InterPro; IPR000413; Integrin_alpha.
DR   InterPro; IPR018184; Integrin_alpha_C_CS.
DR   InterPro; IPR013649; Integrin_alpha_Ig-like_1.
DR   InterPro; IPR048285; Integrin_alpha_Ig-like_2.
DR   InterPro; IPR048286; Integrin_alpha_Ig-like_3.
DR   InterPro; IPR028994; Integrin_alpha_N.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   PANTHER; PTHR23220; INTEGRIN ALPHA; 1.
DR   PANTHER; PTHR23220:SF90; INTEGRIN ALPHA-7; 1.
DR   Pfam; PF01839; FG-GAP; 2.
DR   Pfam; PF08441; Integrin_A_Ig_1; 1.
DR   Pfam; PF20805; Integrin_A_Ig_2; 1.
DR   Pfam; PF20806; Integrin_A_Ig_3; 1.
DR   PRINTS; PR01185; INTEGRINA.
DR   SMART; SM00191; Int_alpha; 5.
DR   SUPFAM; SSF69318; Integrin alpha N-terminal domain; 1.
DR   SUPFAM; SSF69179; Integrin domains; 3.
DR   PROSITE; PS51470; FG_GAP; 7.
DR   PROSITE; PS00242; INTEGRIN_ALPHA; 1.
PE   1: Evidence at protein level;
KW   ADP-ribosylation; Alternative splicing; Calcium; Cell adhesion; Cell shape;
KW   Cleavage on pair of basic residues; Disulfide bond; Glycoprotein; Integrin;
KW   Membrane; Metal-binding; Receptor; Reference proteome; Repeat; Signal;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL          1..33
FT                   /evidence="ECO:0000250"
FT   CHAIN           34..1135
FT                   /note="Integrin alpha-7"
FT                   /id="PRO_0000293124"
FT   CHAIN           34..910
FT                   /note="Integrin alpha-7 heavy chain"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_0000016273"
FT   CHAIN           604..1135
FT                   /note="Integrin alpha-7 70 kDa form"
FT                   /id="PRO_0000398834"
FT   CHAIN           914..1135
FT                   /note="Integrin alpha-7 light chain"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_0000016274"
FT   TOPO_DOM        34..1036
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1037..1057
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1058..1135
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REPEAT          38..103
FT                   /note="FG-GAP 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00803"
FT   REPEAT          110..165
FT                   /note="FG-GAP 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00803"
FT   REPEAT          185..238
FT                   /note="FG-GAP 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00803"
FT   REPEAT          248..305
FT                   /note="FG-GAP 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00803"
FT   REPEAT          306..367
FT                   /note="FG-GAP 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00803"
FT   REPEAT          368..423
FT                   /note="FG-GAP 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00803"
FT   REPEAT          427..486
FT                   /note="FG-GAP 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00803"
FT   REPEAT          1111..1114
FT                   /note="1"
FT   REPEAT          1119..1122
FT                   /note="2"
FT   REPEAT          1127..1130
FT                   /note="3"
FT   REGION          905..933
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1111..1130
FT                   /note="3 X 4 AA repeats of D-X-H-P"
FT   MOTIF           1061..1065
FT                   /note="GFFKR motif"
FT   COMPBIAS        905..921
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         328
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P08648"
FT   BINDING         330
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P08648"
FT   BINDING         332
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P08648"
FT   BINDING         336
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P08648"
FT   BINDING         390
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P08648"
FT   BINDING         392
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P08648"
FT   BINDING         394
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P08648"
FT   BINDING         398
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P08648"
FT   BINDING         448
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250|UniProtKB:P08648"
FT   BINDING         450
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250|UniProtKB:P08648"
FT   BINDING         452
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250|UniProtKB:P08648"
FT   BINDING         454
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250|UniProtKB:P08648"
FT   BINDING         456
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250|UniProtKB:P08648"
FT   SITE            603..604
FT                   /note="Cleavage; by urokinase"
FT   CARBOHYD        86
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        741
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        943
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        979
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        999
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        94..103
FT                   /evidence="ECO:0000250"
FT   DISULFID        140..163
FT                   /evidence="ECO:0000250"
FT   DISULFID        184..197
FT                   /evidence="ECO:0000250"
FT   DISULFID        495..502
FT                   /evidence="ECO:0000250"
FT   DISULFID        508..571
FT                   /evidence="ECO:0000250"
FT   DISULFID        637..643
FT                   /evidence="ECO:0000250"
FT   DISULFID        736..747
FT                   /evidence="ECO:0000250"
FT   DISULFID        894..948
FT                   /note="Interchain (between heavy and light chains)"
FT                   /evidence="ECO:0000250"
FT   DISULFID        955..960
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         1060..1135
FT                   /note="LGFFKRAKHPEATVPQYHAVKILREDRQQFKEEKTGTIQRSNWGNSQWEGSD
FT                   AHPILAADWHPELGPDGHPVSVTA -> CGFFRRNSPSSSFPANYHRAHLAVQPSAMEA
FT                   GGPGTVGWDSSSGRSTLRPLYPSTTQ (in isoform Alpha-7X1A)"
FT                   /evidence="ECO:0000303|PubMed:8126096"
FT                   /id="VSP_002734"
FT   VAR_SEQ         1065..1135
FT                   /note="RAKHPEATVPQYHAVKILREDRQQFKEEKTGTIQRSNWGNSQWEGSDAHPIL
FT                   AADWHPELGPDGHPVSVTA -> CAVPAQRILSIY (in isoform Alpha-
FT                   7X1C)"
FT                   /evidence="ECO:0000303|PubMed:8126096"
FT                   /id="VSP_002735"
FT   MUTAGEN         603
FT                   /note="R->G: Abolishes cleavage by urokinase."
FT                   /evidence="ECO:0000269|PubMed:18940796"
FT   CONFLICT        79..95
FT                   /note="ALPGQQANRTGGLFACP -> DSYPDSRQIAHGRPLCLS (in Ref. 2;
FT                   CAA46170)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        130..133
FT                   /note="SQGA -> PRES (in Ref. 2; CAA46170)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        149
FT                   /note="R -> E (in Ref. 2; CAA46170)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        225..232
FT                   /note="LLFVTNID -> TARVELCAQG (in Ref. 2; CAA46170)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        236..259
FT                   /note="PDQLVYKTLDPADRLTGPAGDLTL -> LAQVDDGPYEAGGEKDQDPRPSPV
FT                   PA (in Ref. 2; CAA46170)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        378
FT                   /note="D -> H (in Ref. 2; CAA46170)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        575..582
FT                   /note="VFQLQENV -> CVPAAGKR (in Ref. 2; CAA46170)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        616
FT                   /note="P -> G (in Ref. 2; CAA46170)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        650
FT                   /note="A -> V (in Ref. 2; CAA46170)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        678..679
FT                   /note="LS -> HG (in Ref. 2; CAA46170)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        833..835
FT                   /note="RDV -> WDE (in Ref. 2; CAA46170)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        949..950
FT                   /note="AQ -> P (in Ref. 2; CAA46170)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        996
FT                   /note="V -> G (in Ref. 3; CAA52346/CAA52347)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1135 AA;  124194 MW;  EEBA7063537A4AF1 CRC64;
     MARIPRCDFL GLPGICYLLS FLLAGLLLPR ASAFNLDVMG AIRKEGEPGS LFGFSVALHR
     QLQPRPQSWL LVGAPQALAL PGQQANRTGG LFACPLSLEE TDCYRVDIDR GANVQKESKE
     NQWLGVSVRS QGAGGKVVTC AHRYESRQRV DQVLETRDVI GRCFVLSQDL AIRDELDGGE
     WKFCEGRPQG HEQFGFCQQG TAATFSPDSH YLIFGAPGTY NWKGLLFVTN IDSSDPDQLV
     YKTLDPADRL TGPAGDLTLN SYLGFSIDSG KGLMRSEELS FVAGAPRANH KGAVVILRKD
     SASRLIPEVV LSGERLTSGF GYSLAVTDLN SDGWADLIVG APYFFERQEE LGGAVYVYMN
     QGGHWADISP LRLCGSPDSM FGISLAVLGD LNQDGFPDIA VGAPFDGDGK VFIYHGSSLG
     VVTKPSQVLE GEAVGIKSFG YSLSGGLDVD GNHYPDLLVG SLADTAALFR ARPVLHVSQE
     IFIDPRAIDL EQPNCADGRL VCVHVKVCFS YVAVPSSYSP IVVLDYVLDG DTDRRLRGQA
     PRVTFPGRGP DDLKHQSSGT VSLKHQHDRV CGDTVFQLQE NVKDKLRAIV VTLSYGLQTP
     RLRRQAPDQG LPLVAPILNA HQPSTQRTEI HFLKQGCGDD KICQSNLQLA QAQFCSRISD
     TEFQALPMDL DGTALFALSG QPFIGLELTV TNLPSDPARP QADGDDAHEA QLLATLPASL
     RYSGVRTLDS VEKPLCLSNE NASHVECELG NPMKRGTQVT FYLILSTSGI TIETTELKVE
     LLLATISEQD LHPVSVRAHV FIELPLSISG VATPQQLFFS GKVKGESAMR SERDVGSKVK
     YEVTVSNQGQ SLNTLGSAFL NIMWPHEIAN GKWLLYPMRV ELEGGQGPEK KGICSPRPNI
     LHLDVDSRDR RRRELGQPEP QEPPEKVEPS TSWWPVSSAE KRNVTLDCAQ GTAKCVVFSC
     PLYSFDRAAV LHVWGRLWNS TFLEEYMSVK SLEVIVRANI TVKSSIKNLL LRDASTVIPV
     MVYLDPVAVV AEGVPWWVIL LAVLAGLLVL ALLVLLLWKL GFFKRAKHPE ATVPQYHAVK
     ILREDRQQFK EEKTGTIQRS NWGNSQWEGS DAHPILAADW HPELGPDGHP VSVTA
//
